Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
4.260
-0.390 (-8.39%)
Oct 25, 2024, 4:00 PM EDT - Market closed
Climb Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Oct '24 Oct 25, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 286 | 74 | 98 | 278 | - | - |
| Market Cap Growth | 179.88% | -23.65% | -64.90% | - | - | - |
| Enterprise Value | 63 | -33 | -32 | 108 | - | - |
| Last Close Price | 4.26 | 2.70 | 3.67 | 10.46 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | - | - |
| Debt / FCF Ratio | 1.75 | -0.02 | -0.01 | - | - | - |
| Quick Ratio | 59.65 | 38.55 | 21.35 | 23.79 | 8.16 | 27.10 |
| Current Ratio | 60.41 | 38.92 | 22.04 | 24.58 | 8.76 | 27.18 |
| Return on Equity (ROE) | -38.35% | -29.72% | -30.58% | -50.16% | -96.74% | - |
| Return on Assets (ROA) | -24.54% | -10.93% | -18.30% | -22.53% | -31.96% | - |
| Return on Capital (ROIC) | -25.04% | -11.31% | -19.03% | -23.55% | -34.42% | - |
| Buyback Yield / Dilution | -6.18% | -2.57% | -114.60% | -460.40% | -31.72% | - |
| Total Shareholder Return | -6.18% | -2.57% | -114.60% | -460.40% | -31.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.